From these results, we suggest that AQP3 and AQP5 may serve as molecular prognostic markers for HCC and that AQP3 overexpression in combination with AQP5 upregulation may be associated with even worse prognosis of HCC patients. This evidence concerns the gene AQP5 and hepatocellular carcinoma.